Bio-Reference Laboratories, a wholly-owned subsidiary of OPKO Health, entered into a third amendment to its credit agreement, dated November 5, 2015 with JPMorgan Chase Bank as administrative agent.

The amendment permitted Bio-Reference and its subsidiaries to dividend cash in the form of an intercompany loan, in an aggregate amount not to exceed $55 million.